ADAPT® Technology is the first and only next generation BioScaffold that completely re-engineers xenograft tissue into a pure collagen scaffold with optimized strength and pliability, superior biocompatibility and unparalleled durability.
Only ADAPT® Tissue Science has 10 years of clinical evidence demonstrating resistance to calcification.(1)
Only ADAPT® based 3D single piece Valve Design is anatomically correct to create less mechanical stress and optimal hemodynamics.(2)
ADAPT® is commercially available. Contact us for more information.
 Neethling W, Rea A, Forster G and Bhirangi K (2020) Performance of the ADAPT-Treated CardioCel® Scaffold in Pediatric Patients With Congenital Cardiac Anomalies: Medium to Long-Term Outcomes. Front. Pediatr. 8:198. doi: 10.3389/fped.2020.00198
 Flat or Curved Pericardial Aortic Valve Cusps: A FiniteElement Study Khee Hiang Lim, Johanes Candra, Joon Hock Yeo, Carlos M. G. Duran The Journal of Heart Valve Disease 2004;13:792-797